• 1
    Jemal A,Siegel R,Ward E,Hao Y,Xu J,Murray T,Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 7196.
  • 2
    Blot WJ,McLaughlin JK,Winn DM,Austin DF,Greenberg RS,Preston-Martin S,Bernstein L,Schoenberg JB,Stemhagen A,Fraumeni JF,Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 32827.
  • 3
    Sturgis EM,Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 142935.
  • 4
    Chaturvedi AK,Engels EA,Anderson WF,Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 6129.
  • 5
    Gillison ML,Koch WM,Capone RB,Spafford M,Westra WH,Wu L,Zahurak ML,Daniel RW,Viglione M,Symer DE,Shah KV,Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 70920.
  • 6
    Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 74454.
  • 7
    D'Souza G,Kreimer AR,Viscidi R,Pawlita M,Fakhry C,Koch WM,Westra WH,Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 10: 194456.
  • 8
    Fakhry C,Westra WH,Li S,Cmelak A,Ridge JA,Pinto H,Forastiere A,Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 2619.
  • 9
    Ernster JA,Sciotto CG,O'Brien MM,Finch JL,Robinson LJ,Willson T,Mathews M. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 2007; 117: 211528.
  • 10
    Skarsgard DP,Groome PA,Mackillop WJ,Zhou S,Rothwell D,Dixon PF,O'Sullivan B,Hall SF,Holowaty EJ. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer 2000; 88: 172838.
  • 11
    Stephens M,Siroonian J. Smoking prevalence, quit attempts and successes. Health Rep 1998; 9: 317.
  • 12
    Ragin CC,Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 181320.
  • 13
    Carvalho AL,Nishimoto IN,Califano JA,Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 80616.
  • 14
    Hoffman HT,Porter K,Karnell LH,Cooper JS,Weber RS,Langer CJ,Ang KK,Gay G,Stewart A,Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 ( Suppl 111): 113.
  • 15
    Calais G,Alfonsi M,Bardet E,Sire C,Germain T,Bergerot P,Rhein B,Tortochaux J,Oudinot P,Bertrand P. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 20816.
  • 16
    Wendt TG,Grabenbauer GG,Rodel CM,Thiel HJ,Aydin H,Rohloff R,Wustrow TP,Iro H,Popella C,Schalhorn A. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998; 16: 131824.
  • 17
    Jeremic B,Shibamoto Y,Milicic B,Nikolic N,Dagovic A,Aleksandrovic J,Vaskovic Z,Tadic L. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 145864.
  • 18
    NCI. SEER cancer statistics review, 1975-2005. Bethesda, MD: NCI, 2008.
  • 19
    Robles SC,Marrett LD,Clarke EA,Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 1988; 41: 495501.
  • 20
    Clarke EA,Marrett LD,Kreiger N. Cancer registration in Ontario: a computer approach. In: JensenOM,ParkinDM,MacLennanR,MuirCS,SkeetRG, eds. Cancer registration principles and methods. Lyon, France: International Agency for Research in Cancer, 1991. 246257.
  • 21
    WHO. The international statistical classification of diseases and health related problems, ICD-10, 2nd edn. Geneva: WHO, 2004.
  • 22
    FritzAG,PercyC,JackA,SobinLH,ParkinMD, eds. International classification of diseases for oncology, ICD-O,3rd edn. Geneva: WHO, 2000.
  • 23
    Armitage D,Berry G,Matthews JNS. Statistical methods for epidemiology. In: Statistical methods in medical research, 4th edn. Oxford: Blackwell Publishing, 2002. 65967.
  • 24
    Ederer F,Axtell L,Cutler S. The relative survival rate: a statistical methodology. NCI Monogr 1961; 6: 10121.
  • 25
    NCI. SEER Summary Staging Manual 2000: Codes and Coding Instructions. Bethesda, Maryland: NCI 2001, Report No.: NIH Pub No. 01-4969.
  • 26
    NCI. SEER Program Coding and Staging Manual 2007. Bethesda, Maryland: NCI 2007, Report No.: NIH Pub. No. 07-5581.
  • 27
    Kim HJ,Fay MP,Feuer EJ,Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 33551.
  • 28
    Klein JP,Moeschberger ML. Tests for trend. In: Survival analysis: techniques for censored and truncated data. New York: Springer-Verlag, 1997. 2169.
  • 29
    Brown CC. The statistical comparison of relative survival rates. Biometrics 1983; 39: 9418.
  • 30
    Mackillop WJ,Zhang-Salomons J,Boyd CJ,Groome PA. Associations between community income and cancer incidence in Canada and the United States. Cancer 2000; 89: 90112.
  • 31
    Boyd CJ,Zhang-Salomons J,Groome PA,Mackillop WJ. Associations between community income and cancer survival in Ontario and the United States. J Clin Oncol 1999; 17: 224455.
  • 32
    Chen AY,Schrag N,Hao Y,Flanders WD,Kepner J,Stewart A,Ward E. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006; 135: 8317.
  • 33
    Giuliano AR,Salmon D. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point. Cancer Epidemiol Biomarkers Prev 2008; 17: 8058.
  • 34
    Trimble CL. Human papillomavirus vaccination should be offered to young males: Counterpoint. Cancer Epidemiol Biomarkers Prev 2008; 17: 809.
  • 35
    Chen AY,Schrag N,Hao Y,Stewart A,Ward E. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 2007; 117: 1621.
  • 36
    IARC. IARC monographs on the evaluation of carcinogenic risks to humans, human papillomaviruses, Vol. 90. Lyon: International Agency for Research on Cancer, 2007.